Millennium Management
PHIO icon

Millennium Management’s Phio Pharmaceuticals PHIO Stock Holding History

Millennium Management’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-95
Closed -$9K – 7449
2022
Q1 		$9K Sell
95
-325
-77% -$30.9K ﹤0.01% 6743
2021
Q4 		$45K Sell
420
-716
-63% -$114K ﹤0.01% 6503
2021
Q3 		$248K Buy
1,136
+1,043
+1,122% +$218K ﹤0.01% 5958
2021
Q2 		$23K Buy
+93
New +$22.9K ﹤0.01% 6423
2017
Q4 		– Sell
-1
Closed -$16K – 4011
2017
Q3 		$16K Buy
+1
New +$34.5K ﹤0.01% 3451

Other funds holding PHIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return